Recent recommendations to lawmakers to reform DSHEA are a wish list, but they demand attentiveness and vigilance, according to the head of one industry trade organization.
Editor’s note: This is the first article in a series on proposed reforms to DSHEA by several consumer groups in a recent letter to Congress.
The Center for Science in the Public Interest (CSPI) and other consumer groups have proposed to members of Congress sweeping reforms to how dietary supplements are regulated in the United States.
The comprehensive proposals were incorporated in a March 10 letter to members of Congress, which urged them to reject a bill that would legalize CBD in dietary supplements.
Dr Rob Wildman, SafetyCall International & Indena among AHPA 2021 Award recipients The American Herbal Products Association has announced the recipients of its 2021 annual AHPA Awards with Herbalife Nutrition, Naturade, and Tony Hayes also being recognized.
The Awards, established in 2006, are given to individuals and organizations that have made significant contributions to the continued success of the herbal products industry. The awards were presented virtually at the annual meeting this week. Every year, AHPA recognizes the hard work and dedication of individuals and organizations that go above and beyond to ensure the continued success of the herbal industry. AHPA and the entire herbal products industry have greatly benefited from their expertise and passion for herbs, said AHPA President Michael McGuffin.
Food and Drug Administration (FDA) to approve cannabidiol (CBD) for use in dietary supplements.
House Resolution 841, also called the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, was introduced by Democratic Oregon Rep. Kurt Schrader and Republican Virginia Rep Morgan Griffith, with five Republican and 12 Democratic co-sponsors. The bill would simply make hemp subject to all the regulations as any other dietary supplement – subject to new dietary ingredient (NDI) filings, Good Manufacturing Practices (GMP) and labeling and marketing provisions.
Under the bill, hemp’s definition as a cannabis plant with less than 0.3 percent tetrahydrocannabinol (THC) – the psychoactive constituent of cannabis – would remain unchanged. The focus on THC also means that other cannabinoids and terpenes within hemp can also be approved for use in dietary supplements.
Over a 26-year period, most new dietary ingredient notifications were met with objections from FDA, government data shows.
Since the mid-1990s, FDA has objected to most new dietary ingredient notifications (NDINs) for one reason or another. This past fiscal year was no different.
In FY20, filed 27 objection letters to NDINs and acknowledged 16 notifications without objection, reflecting an acknowledgement rate of 37.2%, FDA data shows.
Steven Tave, director of FDA’s Office of Dietary Supplement Programs, reminded industry during a 2019 public meeting that “an effective NDI notification process represents FDA s only opportunity to evaluate the safety of a new dietary ingredient before it becomes available to consumers.”